UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY

被引：3
|
作者：
Smolen, J. S. [1 ]
Emery, P. [2 ,3 ]
Rigby, W. [4 ]
Tanaka, Y. [5 ]
Vargas, J. Ignacio [6 ]
Damjanov, N. [7 ]
Jain, M. [8 ]
Song, Y. [9 ]
Khan, N. [9 ]
Enejosa, J. J. [9 ]
Cohen, S. B. [10 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[4] Dartmouth Coll, Hanover, NH 03755 USA
[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[6] Quantum Res, Puerto Varas, Chile
[7] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia
[8] Great Lakes Clin Trials, Chicago, IL USA
[9] AbbVie Inc, N Chicago, IL USA
[10] Metroplex Clin Res Ctr, Dallas, TX USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.961
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0213
引用
收藏
页码：327 / 328
页数：2
相关论文
共 50 条
  • [21] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMIZED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J. S.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A. A.
    Camp, H. S.
    Pangan, A. L.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S52 - S52
  • [22] UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY
    Genovese, Mark C.
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 360 - 361
  • [23] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J. S.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A. A.
    Camp, H. S.
    Pangan, A. L.
    RHEUMATOLOGY, 2019, 58
  • [24] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A.
    Camp, H.
    Pangan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 67 - 68
  • [25] Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naive Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo M.
    Ueki, Yukitaka
    Atsumi, Tatsuya
    Chen, Su
    Friedman, Alan
    Pangan, Aileen L.
    Strand, Vibeke
    van Vollenhoven, Ronald F.
    MODERN RHEUMATOLOGY, 2021, 31 (03) : 534 - 542
  • [26] WHICH STRATEGIES IN RHEUMATOID ARTHRITIS PATIENT WITH INADEQUATE RESPONSE TO METHOTREXATE MONOTHERAPY: THE STRATEGE STUDY
    Flipo, R. -M.
    Gaujoux-Viala, C.
    Hudry, C.
    Zinovieva, E.
    Leutenegger, E.
    Herman-Demars, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 109 - 109
  • [27] Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs Results from a retrospective cohort study
    Floris, Alberto
    Perra, Daniela
    Cangemi, Ignazio
    Congia, Mattia
    Chessa, Elisabetta
    Angioni, Maria Maddalena
    Mangoni, Arduino Aleksander
    Erre, Gian Luca
    Mathieu, Alessandro
    Piga, Matteo
    Cauli, Alberto
    MEDICINE, 2021, 100 (17) : E25481
  • [28] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 47
  • [29] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 643 - 644
12345